Guideline (S2k) on acute therapy and management of anaphylaxis: 2021 update: S2k-Guideline of the German Society for Allergology and Clinical Immunology (DGAKI), the Medical Association of German Allergologists (AeDA), the Society of Pediatric Allergology and Environmental Medicine (GPA), the German Academy of Allergology and Environmental Medicine (DAAU), the German Professional Association of Pediatricians (BVKJ), the Society for Neonatology and Pediatric Intensive Care (GNPI), the German Society of Dermatology (DDG), the Austrian Society for Allergology and Immunology (ÖGAI), the Swiss Society for Allergy and Immunology (SGAI), the German Society of Anaesthesiology and Intensive Care Medicine (DGAI), the German Society of Pharmacology (DGP), the German Respiratory Society (DGP), the patient organization German Allergy and Asthma Association (DAAB), the German Working Group of Anaphylaxis Training and Education (AGATE)

Johannes Ring, Kirsten Beyer, Tilo Biedermann, Andreas Bircher, Matthias Fischer, Thomas Fuchs, Axel Heller, Florian Hoffmann, Isidor Huttegger, Thilo Jakob, Ludger Klimek, Matthias V. Kopp, Claudia Kugler, Lars Lange, Oliver Pfaar, Ernst Rietschel, Franziska Rueff, Sabine Schnadt, Roland Seifert, Britta StöckerRegina Treudler, Christian Vogelberg, Thomas Werfel, Margitta Worm, Helmut Sitter, Knut Brockow

Research output: Contribution to journalArticlepeer-review

101 Scopus citations
Original languageEnglish
JournalAllergo Journal International
Volume30
Issue number1
DOIs
StatePublished - Feb 2021

Keywords

  • Adrenalin
  • Anaphylaxis
  • Auto-injector
  • COVID-19
  • Drug allergy
  • Emergency management
  • Food allergy
  • Group education
  • Pharmacotherapy
  • Vaccination

Cite this